Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | |
Sep. 30, 2017 | Dec. 28, 2017 | |
Document And Entity Information | ||
Entity Registrant Name | NATURAL HEALTH FARM HOLDINGS INC | |
Entity Central Index Key | 1,621,697 | |
Document Type | 10-K | |
Trading Symbol | NHEL | |
Document Period End Date | Sep. 30, 2017 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --09-30 | |
Entity a Well-known Seasoned Issuer | No | |
Entity a Voluntary Filer | No | |
Entity's Reporting Status Current | Yes | |
Entity Filer Category | Smaller Reporting Company | |
Entity Public Float | $ 0 | |
Entity Common Stock, Shares Outstanding | 150,150,000 | |
Document Fiscal Period Focus | FY | |
Document Fiscal Year Focus | 2,017 |
Balance Sheets
Balance Sheets - USD ($) | Sep. 30, 2017 | Sep. 30, 2016 |
Current Assets | ||
Cash and cash equivalents | ||
Prepaid Expenses | 696 | |
Total Current Assets | 696 | |
Total Assets | 696 | |
Current Liabilities | ||
Advance from affiliate | 80,137 | |
Advance from director | 5,703 | |
Total Current Liabilities | 80,137 | 5,703 |
Total Liabilities | 80,137 | 5,703 |
Stockholders' Deficit | ||
Common Stock, $0.001 par value, 500,000,000 shares authorized, 150,150,000 shares issued and outstanding | 150,150 | 150,150 |
Additional Paid in Capital | (111,821) | (126,050) |
Accumulated Deficit | (118,466) | (29,107) |
Total Stockholders' Deficit | (80,137) | (5,007) |
Total Liabilities and Stockholders' Deficit | $ 696 |
Balance Sheets (Parenthetical)
Balance Sheets (Parenthetical) - $ / shares | Sep. 30, 2017 | Nov. 30, 2016 | Sep. 30, 2016 |
Statement of Financial Position [Abstract] | |||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | |
Common stock, authorized | 500,000,000 | 500,000,000 | 500,000,000 |
Common stock, issued | 150,150,000 | 150,150,000 | |
Common stock, outstanding | 150,150,000 | 150,150,000 |
Statements of Operations
Statements of Operations - USD ($) | 12 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Income Statement [Abstract] | ||
Revenues | $ 1,995 | |
Cost of Goods Sold | ||
Gross Profit | 1,995 | |
Operating Expenses: | ||
Filing fees | 9,093 | |
Professional fees | 63,278 | 20,905 |
General and Administrative | 16,988 | 1,287 |
Total Operating Expenses | 89,359 | 22,192 |
Loss from Operations | (89,359) | (20,197) |
Other Income (Expenses) | ||
Loss Before Income Tax | (89,359) | (20,197) |
Provision for Income Tax | ||
Net Loss | $ (89,359) | $ (20,197) |
Basic and Dilutive Net Loss Per Share (in dollars per share) | $ 0 | $ 0 |
Weighted Average Number of Shares Outstanding - Basic and Diluted (in shares) | 150,150,000 | 137,760,246 |
Statements of Changes in Stockh
Statements of Changes in Stockholders' Deficit - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Total | |
Balance at beginning at Sep. 30, 2015 | $ 120,000 | $ (116,000) | $ (8,910) | $ (4,910) | |
Balance at beginning (in shares) at Sep. 30, 2015 | [1] | 120,000,000 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Shares issued for cash | $ 30,150 | (10,050) | 20,100 | ||
Shares issued for cash (in shares) | [1] | 30,150,000 | |||
Net Loss | (20,197) | (20,197) | |||
Balance at ending at Sep. 30, 2016 | $ 150,150 | (126,050) | (29,107) | (5,007) | |
Balance at ending (in shares) at Sep. 30, 2016 | [1] | 150,150,000 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Forgiveness of advance by former directors | 14,229 | 14,229 | |||
Shares issued for cash | $ 20,100 | ||||
Shares issued for cash (in shares) | 30,150,000 | ||||
Net Loss | (89,359) | $ (89,359) | |||
Balance at ending at Sep. 30, 2017 | $ 150,150 | $ (111,821) | $ (118,466) | $ (80,137) | |
Balance at ending (in shares) at Sep. 30, 2017 | [1] | 150,150,000 | |||
[1] | Adjusted for 30:1 forward stock split on November 4, 2016. |
Statements of Cash Flows
Statements of Cash Flows - USD ($) | 12 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Cash Flows from Operating Activities: | ||
Net Loss | $ (89,359) | $ (20,197) |
Changes in operating assets and liabilities | ||
(Increase) decrease in prepaid expense | 696 | (696) |
Net Cash Used in Operating Activities | (88,663) | (20,893) |
Cash Flows from Financing Activities | ||
Proceeds from sale of common stock | 20,100 | |
Advance from affiliate | 80,137 | |
Cash advance from director | 8,526 | 366 |
Net Cash Provided by Financing Activities | 88,663 | 20,466 |
Net Increase in Cash and Cash Equivalents | (427) | |
Cash and Cash Equivalents, Beginning of the Period | 427 | |
Cash and Cash Equivalents, End of the Period | ||
Supplemental Disclosures of Cash Flow Information: | ||
Cash paid for Income Taxes | ||
Cash paid for Interest | ||
Supplemental disclosures of non-cash investing and financing activities: | ||
Forgiveness of debt by a former director | $ 14,229 |
NATURE OF OPERATIONS AND GOING
NATURE OF OPERATIONS AND GOING CONCERN | 12 Months Ended |
Sep. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
NATURE OF OPERATIONS AND GOING CONCERN | NOTE 1: NATURE OF OPERATIONS AND GOING CONCERN Nature of Operations Natural Health Farm Holdings Inc. (the “Company”, “We”, “Its”, and “NHFH”) was incorporated under the laws of the State of Nevada on July 10, 2014 (inception). The Company is a development stage company and is looking to acquire profitable business operations. On November 30, 2016, the Company filed a certificate of amendment to its articles of incorporation with the Nevada Secretary of State to change its name from Amber Group Inc. to Natural Health Farm Holdings Inc., and effectuated a 30:1 forward stock split of its common stock and increased its authorized share capital to 500,000,000 (Five Hundred Million). This amendment was unanimously approved by the Company’s board of directors on November 29, 2016, and with the stockholders holding a majority of the Company’s voting power. On March 16, 2017, Financial Industry Regulatory Authority (FINRA) approved the corporate name change to Natural Health Farm Holdings Inc., approved the increase in the Company’s authorized shares of common stock to 500,000,000 shares, and approved 30:1 forward stock split effective March 17, 2017. The new trading symbol for our common stock is “NHEL”. Going Concern The Company has faced significant liquidity shortages as shown in the accompanying financial statements. As of September 30, 2017, the Company's total liabilities exceeded its total assets by $80,137. The Company has recorded a net loss of $89,359 for the year ended September 30, 2017 and has an accumulated deficit of $118,466 as of September 30, 2017. Net cash used in operating activities for the year ended September 30, 2017 was $88,663. The Company has had difficulty in obtaining working lines of credit from financial institutions and trade credit from vendors, management has been able to (i) obtain concessions on forgiveness of debt of $14,229 from a former officer and director, (ii) obtain advance from affiliate of $80,137 to continue its growth. Although the Company has not earned any revenues during the fiscal year ended September 30, 2017 and minimal revenues since July 10, 2014 (Inception date), the Company is continuing to focus its efforts on actively looking to acquire profitable operating business. If the Company is not successful with its efforts to acquire profitable business, the Company will experience a shortfall in cash and it will be necessary to further reduce its operating expenses in a manner or obtain funds through equity or debt financing in sufficient amounts to avoid the need to curtail its operations after September 30, 2017. Given the liquidity and credit constraints in the markets, the business may suffer. However, there can be no assurance that the Company would be able to secure additional funds if needed and that if such funds were available on commercially reasonable terms or in the necessary amounts, and whether the terms or conditions would be acceptable to the Company. In such case, the reduction in operating expenses might need to be substantial in order for the Company to generate positive cash flow to sustain its operations. |
SUMMARY OF SIGNIFCANT ACCOUNTIN
SUMMARY OF SIGNIFCANT ACCOUNTING POLICIES | 12 Months Ended |
Sep. 30, 2017 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts receivables, valuation of long-lived assets, accounts payable and accrued liabilities. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Cash and Cash Equivalents The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2017 and 2016, respectively. Fair value of Financial Instruments and Fair Value Measurements Accounting Standards Codification (“ASC”) 820, “ Fair Value Measurements and Disclosures”, Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of accrued expense, advance from affiliate, and loan payable to related party. Pursuant to ASC 820, “ Fair Value Measurements and Disclosures” Financial Instruments” The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis: Description Level 1 Level 2 Level 3 None $ - $ - $ - The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2016 on a recurring basis: Description Level 1 Level 2 Level 3 None $ - $ - $ - Revenue Recognition Revenue is recognized when earned, as reasonably determinable in accordance with ACS 605-15-25, “Revenue Recognition.” The Company's revenue recognition policy is based on the revenue recognition criteria established under the SEC's Staff Accounting Bulletin No. 104. The criteria and how the Company satisfies each element is as follows: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred per the terms of the signed contract; (3) the price is fixed and determinable; and (4) collectability is reasonable assured. Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “ Income Taxes” The Company follows the provisions of ASC 740, “ Income Taxes Earnings (Loss) Per Share The Company computes net earnings (loss) per share in accordance with ASC 260, “ Earnings per Share” Concentration of Credit Risk The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through September 30, 2017 and 2016. The Company’s bank balance did not exceed FDIC insured amounts at September 30, 2017 and 2016, respectively. Recent Accounting Pronouncements In November 2016, the FASB issued Accounting Standards Update No. 2016-18, “ Statement of Cash Flows (Topic 230): Restricted Cash” (“ASU 2016-18”) In August 2016, the FASB issued ASU 2016-15, “ Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In February 2016, FASB issued Accounting Standards Update 2016-02, “ Leases (Topic 842 In January 2016, the FASB issued ASU 2016-01, “ Financial Instruments - Overall Recognition and Measurement of Financial Assets and Financial Liabilities . ” The main objective of this update is to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The new guidance addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. This ASU is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements. |
ADVANCE FROM AN AFFILIATE
ADVANCE FROM AN AFFILIATE | 12 Months Ended |
Sep. 30, 2017 | |
Advance From Affiliate | |
ADVANCE FROM AN AFFILIATE | NOTE 3 – ADVANCE FROM AN AFFILIATE The Company has received an advance from an affiliate for its working capital needs. The advance received is non-interest bearing, unsecured and payable on demand is summarized as follows. Balance Balance September 30, 2017 September 30, 2016 Advance from an affiliate $ 80,137 $ - Total $ 80,137 $ - |
ADVANCES FROM DIRECTORS
ADVANCES FROM DIRECTORS | 12 Months Ended |
Sep. 30, 2017 | |
Related Party Transactions [Abstract] | |
ADVANCES FROM DIRECTORS | NOTE 4 – ADVANCES FROM DIRECTORS During the year ended September 30, 2017, the Company received cash proceeds of $8,526 from a former director as a short-term advance, for its working capital needs. The Company received cash proceeds of $5,703 from the same former director as a short-term advance, during the fiscal year ended September 30, 2016. The entire short-term advance amounting to $14,229 was forgiven by the former director as of September 30, 2017, and is recorded as a contribution to additional paid in capital as of September 30, 2017 (Note 6). |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 12 Months Ended |
Sep. 30, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 5 – COMMITMENTS AND CONTINGENCIES Litigation Costs and Contingencies From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Other than as set forth below, management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results. In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received. If a loss is considered probable and the amount can be reasonable estimated, the Company recognizes an expense for the estimated loss. |
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT | 12 Months Ended |
Sep. 30, 2017 | |
Equity [Abstract] | |
STOCKHOLDERS' DEFICIT | NOTE 6: STOCKHOLDERS’ DEFICIT The Company’s capitalization at September 30, 2017 was 500,000,000 authorized common shares with a par value of $0.001 per share. Common Stock On November 30, 2016, the Company increased the authorized share capital from 75,000,000 shares of common stock to 500,000,000 shares of common stock. In addition, the Company effectuated a 30:1 forward stock split of the common stock. During the fiscal year ended September 30, 2017, two former directors of the Company forgave their short-term advances of $4,982 and $9,247 totaling $14,229 payable to them. Such amounts are recorded as additional paid in capital as of September 30, 2017 (Note 4). During the fiscal year ended September 30, 2016, the Company sold 30,150,000 shares of common stock for cash proceeds of $20,100. As a result of all common stock issuances, the Company had 150,150,000 shares of common stock issued and outstanding as of September 30, 2017. |
INCOME TAX
INCOME TAX | 12 Months Ended |
Sep. 30, 2017 | |
Income Tax Disclosure [Abstract] | |
INCOME TAX | NOTE 7: INCOME TAX Income tax expense for the years ended September 30, 2017 and 2016 is summarized as follows: The provision for Federal income tax consists of the following: September 30, September 30, 2016 Federal income tax benefit attributable to: Current Operations $ 30,382 $ 6,867 Less: valuation allowance (30,382 ) (6,867 ) Net provision for Federal income taxes $ - $ - The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows: September 30, September 30, 2016 Deferred tax asset attributable to: Net operating loss carryover $ 40,278 $ 9,896 Less: valuation allowance (40,278 ) (9,896 ) Net deferred tax asset $ - $ - Deferred income taxes are provided for the tax effects of transactions reported in the financial statements and consist of deferred taxes related primarily to differences between the bases of certain assets and liabilities for financial and tax reporting. The deferred taxes represent the future tax return consequences of those differences, which will either be deductible or taxable when the assets and liabilities are recovered or settled. At September 30, 2017 and 2016, the Company had an accumulated deficit of $118,466 and $29,107 for U.S. federal tax purposes available to offset future taxable income expiring on various dates through 2034. The Company has recorded a 100% valuation allowance on the deferred tax assets due to the uncertainty of its realization. The net change in the valuation allowance for the year ended September 30, 2017 and 2016 was an increase of $30,382 and $6,867, respectively. In the normal course of business, the Company’s income tax returns are subject to examination by various taxing authorities. Such examinations may result in future tax and interest assessment by these taxing authorities. Accordingly, the Company believes that it is more likely than not that it will realize the benefits of tax positions it has taken in its tax returns or for the amount of any tax benefit that exceeds the cumulative probability threshold in accordance with FASB ASC 740. Differences between the estimated and actual amounts determined upon ultimate resolution, individually or in the aggregate, are not expected to have a material adverse effect on the company’s financial position. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for unrecognized tax benefits. As of September 30, 2017, tax years 2015 and 2016 remain open for examination by the Internal Revenue Service (“IRS”). The Company has received no notice of audit from the IRS for any of the open tax years. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Sep. 30, 2017 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 8: SUBSEQUENT EVENTS Management has evaluated the subsequent events that have occurred after the balance sheet date of September 30, 2017, through the date which the financial statements were available to be issued. Based upon their review, no items were identified that would impact the accounting for events or transactions in the current period or require additional disclosures. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Sep. 30, 2017 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts receivables, valuation of long-lived assets, accounts payable and accrued liabilities. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2017 and 2016, respectively. |
Fair value of Financial Instruments and Fair Value Measurements | Fair value of Financial Instruments and Fair Value Measurements Accounting Standards Codification (“ASC”) 820, “ Fair Value Measurements and Disclosures”, Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of accrued expense, advance from affiliate, and loan payable to related party. Pursuant to ASC 820, “ Fair Value Measurements and Disclosures” Financial Instruments” The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis: Description Level 1 Level 2 Level 3 None $ - $ - $ - The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2016 on a recurring basis: Description Level 1 Level 2 Level 3 None $ - $ - $ - |
Revenue Recognition | Revenue Recognition Revenue is recognized when earned, as reasonably determinable in accordance with ACS 605-15-25, “Revenue Recognition.” The Company's revenue recognition policy is based on the revenue recognition criteria established under the SEC's Staff Accounting Bulletin No. 104. The criteria and how the Company satisfies each element is as follows: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred per the terms of the signed contract; (3) the price is fixed and determinable; and (4) collectability is reasonable assured. |
Income Taxes | Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “ Income Taxes” The Company follows the provisions of ASC 740, “ Income Taxes |
Earnings (Loss) Per Share | Earnings (Loss) Per Share The Company computes net earnings (loss) per share in accordance with ASC 260, “ Earnings per Share” |
Concentration of Credit Risk | Concentration of Credit Risk The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through September 30, 2017 and 2016. The Company’s bank balance did not exceed FDIC insured amounts at September 30, 2017 and 2016, respectively. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In November 2016, the FASB issued Accounting Standards Update No. 2016-18, “ Statement of Cash Flows (Topic 230): Restricted Cash” (“ASU 2016-18”) In August 2016, the FASB issued ASU 2016-15, “ Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In February 2016, FASB issued Accounting Standards Update 2016-02, “ Leases (Topic 842 In January 2016, the FASB issued ASU 2016-01, “ Financial Instruments - Overall Recognition and Measurement of Financial Assets and Financial Liabilities . ” The main objective of this update is to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The new guidance addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. This ASU is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company is currently evaluating this guidance to determine the impact it may have on its financial statements. |
SUMMARY OF SIGNIFICANT ACCOUN16
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 12 Months Ended |
Sep. 30, 2017 | |
Accounting Policies [Abstract] | |
Schedule of assets and liabilities measured and recognized at fair value | The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2017 on a recurring basis: Description Level 1 Level 2 Level 3 None $ - $ - $ - The following table presents assets and liabilities that were measured and recognized at fair value as of September 30, 2016 on a recurring basis: Description Level 1 Level 2 Level 3 None $ - $ - $ - |
ADVANCE FROM AN AFFILIATE (Tabl
ADVANCE FROM AN AFFILIATE (Tables) | 12 Months Ended |
Sep. 30, 2017 | |
Advance From Affiliate Tables | |
Schedule of advance from affiliate | The advance received is non-interest bearing, unsecured and payable on demand is summarized as follows. Balance Balance September 30, 2017 September 30, 2016 Advance from an affiliate $ 80,137 $ - Total $ 80,137 $ - |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Sep. 30, 2017 | |
Income Tax Disclosure [Abstract] | |
Schedule of provision for federal income tax | The provision for Federal income tax consists of the following: September 30, September 30, 2016 Federal income tax benefit attributable to: Current Operations $ 30,382 $ 6,867 Less: valuation allowance (30,382 ) (6,867 ) Net provision for Federal income taxes $ - $ - |
Schedule of deferred tax amount | The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows: September 30, September 30, 2016 Deferred tax asset attributable to: Net operating loss carryover $ 40,278 $ 9,896 Less: valuation allowance (40,278 ) (9,896 ) Net deferred tax asset $ - $ - |
NATURE OF OPERATIONS AND GOIN19
NATURE OF OPERATIONS AND GOING CONCERN (Details Narrative) - USD ($) | Nov. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 |
Description of forward stock split | 30:1 forward stock split | ||
Increased authorized share capital | 500,000,000 | 500,000,000 | 500,000,000 |
Total liabilities | $ 80,137 | $ 5,703 | |
Net loss | (89,359) | (20,197) | |
Accumulated deficit | (118,466) | (29,107) | |
Net cash used in operating activities | (88,663) | (20,893) | |
Advance from affiliate | 80,137 | ||
Former Director [Member] | |||
Forgiveness of debt | $ 14,229 |
SUMMARY OF SIGNIFICANT ACCOUN20
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) | Sep. 30, 2017 | Sep. 30, 2016 |
Level 1 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets and liabilities at fair value | ||
Level 2 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets and liabilities at fair value | ||
Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets and liabilities at fair value |
ADVANCE FROM AN AFFILIATE (Deta
ADVANCE FROM AN AFFILIATE (Details) - USD ($) | Sep. 30, 2017 | Sep. 30, 2016 |
Advance From Affiliate | ||
Advance from an affiliate | $ 80,137 | |
Total | $ 80,137 |
ADVANCES FROM DIRECTORS (Detail
ADVANCES FROM DIRECTORS (Details Narrative) - USD ($) | 12 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Defined Benefit Plan Disclosure [Line Items] | ||
Advance from former director | $ 8,526 | $ 5,703 |
Former Director [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Forgiveness of debt | $ 14,229 |
STOCKHOLDERS' DEFICIT (Details
STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($) | Nov. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 |
Previously common stock, authorized | 75,000,000 | ||
Revised common stock, authorized | 500,000,000 | 500,000,000 | 500,000,000 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | |
Description of forward stock split | 30:1 forward stock split | ||
Number of shares issued upon cash | 30,150,000 | ||
Value of shares issued upon cash | $ 20,100 | $ 20,100 | |
Common stock, issued | 150,150,000 | 150,150,000 | |
Common stock, outstanding | 150,150,000 | 150,150,000 | |
Former Director [Member] | |||
Forgiveness of debt | $ 14,229 | ||
One Former Director [Member] | |||
Forgiveness of debt | 4,982 | ||
Second Former Director [Member] | |||
Forgiveness of debt | $ 9,247 |
INCOME TAX (Details)
INCOME TAX (Details) - USD ($) | 12 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Federal income tax benefit attributable to: | ||
Current Operations | $ 30,382 | $ 6,867 |
Less: valuation allowance | (30,382) | (6,867) |
Net provision for Federal income taxes |
INCOME TAX (Details 1)
INCOME TAX (Details 1) - USD ($) | Sep. 30, 2017 | Sep. 30, 2016 |
Deferred tax asset attributable to: | ||
Net operating loss carryover | $ 40,278 | $ 9,896 |
Less: valuation allowance | (40,278) | (9,896) |
Net deferred tax asset |
INCOME TAX (Details Narrative)
INCOME TAX (Details Narrative) - USD ($) | 12 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Income Tax Disclosure [Abstract] | ||
Income tax rate | 34.00% | |
Accumulated deficit | $ (118,466) | $ (29,107) |
Net operating loss carry forward expired | 2,034 |